Abstract
Parallel to the rapid development of clinical MRI, MR spectroscopy (MRS) has, after starting as an analytical tool used in chemistry and physics, evolved to a noninvasive clinical examination. Most common neuroradiological diagnostic indications for MRS are functional inborn errors, neonatal hypoxia, ischaemia, metabolic diseases, white matter and degenerative diseases, epilepsy, inflammation, infections and intracranial neoplasm. Compared to CT and MRI, well-established morphological diagnostic tools, MRS provides information on the metabolic state of brain tissue. We review the clinical impact of MRS in diagnosis of tumours and their differentiation from non-neoplastic lesions.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received: 3 April 2000 Accepted: 1 September 2000
Rights and permissions
About this article
Cite this article
Burtscher, I., Holtås, S. Proton magnetic resonance spectroscopy in brain tumours: clinical applications. Neuroradiology 43, 345–352 (2001). https://doi.org/10.1007/s002340000427
Issue Date:
DOI: https://doi.org/10.1007/s002340000427